Senior director, country manager, switzerland
BaselRevolution Medicines
...pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑XXXX), a RAS(ON) G12 C‑selective inhibitor; zoldonrasib (RMC‑XXXX), a RAS(ON) G12 D‑selective [...]
Kategorie Handel